Dr. Jeffrey Scott Overcash, MD

Dr. Overcash practices at Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare.

Dr. Overcash's NPI, 1104814680, was assigned on October 10, 2005. Dr. Overcash graduated from University of North Carolina School of Medicine in 2001. Dr. Overcash's California license number on file is A104007.

Dr. Overcash's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Drive Box 58, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 465-0711.

Dr. Overcash's primary practice is Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare. The medical group on file is TeamHealth.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Overcash practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Overcash's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Overcash is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Overcash's licenses on file in 4 states: California, North Carolina, Florida and Hawaii.

CMS data shows 16 Medicare services from Dr. Overcash across 1 procedure code in 2024, for 20 Medicare patients. Medicare paid $2,205 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Overcash in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Overcash's median patient age at 63, with 36% women.

Dr. Overcash accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Overcash, published from 2019 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Anti-Bacterial Agents, Skin Diseases, Bacterial and Double-Blind Method. Dr. Overcash has published most often in Antimicrob Agents Chemother. Dr. Overcash's most frequent co-authors are Robert Lawrence Gottlieb, MD, PhD, Barry Heller, MD and Wesley Hamilton Self, MD.

Dmand AI links Dr. Overcash to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Migraine Disorders and Diabetes Mellitus. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Overcash that name 7 trials.

CMS Open Payments shows 27 general payments to Dr. Overcash from 6 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 50% of the total. Pfizer Inc. paid the most, $3,200. It also lists 66 research payments totaling $197,480 from 2016 to 2025, naming 7 clinical trials.

Dr. Overcash graduated from University of North Carolina School of Medicine in 2001.

Dr. Overcash is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.